PRINCETON, N.J., May 2, 2017 /PRNewswire/ -- Quartesian, a leading data clinical research organization (CRO) known for delivering"Clinical Data Your Way" for early and late-stage clinical studies, today announced an expanded relationship with Medidata, the leading global provider of cloud-based solutions and data analytics for clinical research. Building on its expertise in Medidata's
"Expansion of our Rave skillsets into an FSP model provides more flexibility for our customers. Whether they need full-service project work or FSP to meet their Medidata needs, Quartesian has the experienced staff to meet these requirements," said Soumitra Chowdhury, Quartesian's COO. "Investments in the talented pool of Medidata experts in India is key to our growth as more of our customers, including small to midsize pharma and biotechs, ask for their R&D programs to be built on the Medidata platform."
"We are pleased that Quartesian is further realizing the benefits of Medidata's unified technology platform, expanding its FSP offering for flexible and cost-efficient clinical trial solutions," said Rick Bernstein, Medidata's VP of global partnerships. "We share Quartesian's mission of helping our life sciences customers advance their scientific goals, which is why we're excited to continue to provide the Quartesian team with the right tools, data insights and resources to drive smart, meaningful R&D and to accelerate hope for patients on a global scale."
A certified Medidata partner since 2014, Quartesian has accreditations in Rave, Medidata Coder® and Medidata TSDV, and is in the process of becoming accredited in Medidata Balance® and Medidata Patient Cloud ePRO. Over the last 2.5 years, Quartesian has seen significant increase in the demand for these skillsets. With its growing expertise in key Medidata areas, Quartesian is consistently able to rapidly deploy high quality, cost-efficient clinical data services for many of its life sciences customers and CRO partners.
About QuartesianQuartesian LLC was formed in January 2003 and is headquartered in Princeton, N.J. with the goal of providing "Clinical Data Your Way" to its clients. This goal is accomplished by providing clinical data services faster, more efficient and cost-effective than ever thought possible. The founding members of Quartesian rely not only on their technical expertise, but also on their experience as past clients of clinical service providers. Quartesian prides itself on its flexibility, responsiveness, adherence to client specifications and timelines for all projects conducted anywhere in the world. We have worked with over 100+ pharmaceutical, biotechnology, generic, and medical device companies with 100% repeat business track record and no change orders. Learn more about Quartesian at www.quartesian.com.
Quartesian Contact: Stephen BoccardoSr. VP Business Development and Commercial Strategy609.454.3312 email@example.com
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/quartesian-extends-medidata-expertise-to-fsp-offering-300448774.html
Subscribe to our Free Newsletters!
Neuroblastoma is a very rare type of childhood cancer that develops in immature nerve cells ...
Video-electroencephalography monitoring is a diagnostic technique that records the electrical ...
Myomectomy is a surgery that is done to remove fibroids, which are non-cancerous growths of the ...View All